Amniotic fluid alpha-fetoprotein determination at the time of genetic amniocentesis: Has it outlived its usefulness?

Journal of Ultrasound in Medicine

Volumn 15, Issue 11, 1996, Pages 735-739

  Shields, Laurence E ^a   Uhrich, Stefanie B ^a   Komarniski, Cathy A ^a   Wener, Mark H ^a   Winter, Thomas C ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholinesterase; Alphafeteprotein; Amniocentesis; Amniotic fluid; Ultrasonography

Indexed keywords

FETAL MONITORING; OBSTETRICS;

ACETYLCHOLINESTERASE; AMNIOTIC FLUID ALPHA FETOPROTEIN LEVELS; GENETIC AMNIOCENTESIS; ULTRASONOGRAPHY;

ULTRASONIC IMAGING;

ACETYLCHOLINESTERASE; ALPHA FETOPROTEIN;

AMNIOCENTESIS; AMNION FLUID ANALYSIS; ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FETUS; FETUS ECHOGRAPHY; FETUS MALFORMATION; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

EID: 0030298372     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.1996.15.11.735     Document Type: Article

References (28)

1. UK Collaborative Study on Alpha-fetoprotein in Relation to Neural Tube Defects: Amniotic fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida. Lancet 2:651, 1979
2. Milunsky A: Prenatal detection of neural tube defects. VI. Experience with 20,000 pregnancies. JAMA 244:2731, 1980
3. Lindfors KK, McGahan JP, Tennant FP, et al: Midtrimester screening for open neural tube defects: Correlation of sonography with amniocentesis results. AJR 149:141, 1987
4. Wilson GN, Raj A, Waterson JR, et al: Detection of neural tube defects with alpha-fetoprotein measurement in amniotic fluid: A protocol for managing elevated values. J Reprod Med 31:157, 1986
5. Campbell J, Gilbert WM, Nicolaides KH, et al: Ultrasound screening for spina bifida: Cranial and cerebellar signs in a high risk population. Obstet Gynecol 70:247, 1987
6. Van den Hof MC, Nicolaides KH, Campbell J, et al: Evaluation of lemon and banana signs in one hundred thirty fetuses with open spina bifida. Am J Obstet Gynecol 162:322, 1990
7. Nadal AS, Green JK, Holmes LB, et al: Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations. N Engl J Med 323:557, 1990
8. Sepulveda W, Donaldson A, Johnson RD, et al: Are routine alpha-fetoprotein and acetylcholinesterase determinations still necessary at second trimester amniocentesis? Impact of high-resolution ultrasonography. Obstet Gynecol 85:107, 1995
9. Haddow JE, Morin ME, Holman MS, et al: Acetylcholinesterase and fetal malformations: Modified qualitative technique for diagnosis of neural tube defects. Clin Chem 27:61, 1981
10. Wald NJ, Barlow RD, Cuckle HS, et al: Ratio of amniotic fluid acetylcholinesterase to pseudocholinesterase as an antenatal diagnostic test for exomphalos and gastroschisis. Br J Obstet Gynaecol 91:882, 1984
11. American College of Obstetricians and Gynecologists: Ultrasonography in pregnancy. ACOG Techn Bull 187:1, 1994
12. Leopold G: Antepartum obstetrical guidelines. J Ultrasound Med 5:241, 1986
13. Summitt RL: Amniotic fluid alpha-fetoprotein in prenatal diagnosis of fetal neural tube defects. JAMA 244:2754, 1980
14. Crandall BF, Matsumoto M, Perdue S: Amniotic fluid-AFP in Down syndrome and other chromosome abnormalities. Prenat Diagn 8:255, 1988
15. Crandall BF, Matsumoto M: Risk associated with an elevated amniotic fluid alpha-fetoprotein level. Am J Med Genet 39:64, 1991
16. Crandall BF, Matsumoto M: Routine amniotic fluid alpha-fetoprotein measurement in 34,000 pregnancies. Am J Obstet Gynecol 149:744, 1984
17. Drugan A, Johnson MP, Dvorin E, et al: Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein. Fetal Ther 4:88, 1989
18. Nelson NL, Filly RA, Goldstein RB, et al: The AIUM/ACR antepartum obstetrical sonographic guidelines: Expectations for detection of anomalies. J Ultrasound Med 12:189, 1993
19. Hogge WA, Hogge JS, Schnatterly PT, et al: Congenital nephrosis: Detection of index cases through maternal serum alpha-fetoprotein screening. Am J Obstet Gynecol 167:1330, 1992
20. Ghidini A, Alvarez M, Silverberg G, et al: Congenital nephrosis in low-risk pregnancies. Prenat Diagn 14:599, 1994
21. Albright SG, Warner AA, Seeds JW, et al: Congenital nephrosis as a cause of elevated alpha-fetoprotein. Obstet Gynecol 76:969, 1990
22. Achiron R, Hamiel Pinchas O, Engelberg S, et al: Aplasia cutis congenita associated with epidermolysis bullosa and pyloric atresia: The diagnostic role of prenatal ultrasonography. Prenat Diagn 12:765, 1992
23. Dror Y, Gelman Kohan Z, Hagai Z, et al: Aplasia cutis congenita, elevated alpha-fetoprotein, and a distinct amniotic fluid acetylcholinesterase electrophoretic band. Am J Perinatal 11:149, 1994
24. Shah YG, Moodley S: Report of a case with aplasia cutis congenita, elevated amniotic fluid alpha-fetoprotein, and positive acetylcholinesterase band. Am J Perinatol 9:411, 1992
25. Warner AA, Pettenati MJ, Burton BK: Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 75:64, 1990
26. Brumfield CG, Cloud GA, Finley SC, et al: Amniotic fluid alpha-fetoprotein levels and pregnancy outcome. Am J Obstet Gynecol 157:822, 1987
27. LeFevre ML, Bain RP, Ewigman BGF, et al: A randomized trial of prenatal ultrasonographic screening: Impact on maternal management and outcome. Am J Obstet Gynecol 169:483, 1993
28. Platt LD, Feuchtbaum L, Filly R, et al: The California Maternal Serum Alpha-Fetoprotein Screening Program: The role of ultrasonography in the detection of spina bifida. Am J Obstet Gynecol 166:1328, 1992